HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 553-564 of 1,979
Drug study icon
TerminatedNCT03210480

SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)

Official study title

Clinical Evaluation of Switching to Lithiofor® (Lithium Sulphate Slow -Release, Li-SR Tablets) From Carbolithium® (Lithium Carbonate Immediate-Release, Li-IR, Capsules) in Bipolar Patients, Poorly Tolerant to Lithium Immediate-release Treatment.

This study ended early.

Multiple locations, including Orbetello
BipolarityMedication studyAges 18–65
Countries
Italy
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Drug study icon
CompletedNCT00097266

Aripiprazole in people with Acute Bipolar Mania

Official study title

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Anaheim
BipolarityMedication studyAges 18+
Countries
United States, Bulgaria, Croatia, + 4 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00350857

The Young Adult and Pediatric Bipolar Study

What is this study about?

This study evaluated the safety and effectiveness of Extended-Release Carbamazepine for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Altamonte Springs
BipolarityMedication studyAges 10–17
Countries
United States
Sponsor
Validus Pharmaceuticals
Drug study icon
CompletedEUCTR 2008-000281-23

Melatonin in Acute Mania Investigation (MIAMI-UK)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
BipolarityHistorical research recordAges 18–65
Countries
United Kingdom
Sponsor
University of Oxford (University)
Drug study icon
CompletedEUCTR 2017-002225-38

A Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects with Bipolarity type I

Official study title

A Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects with Bipolar I Disorder

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
BipolarityHistorical research record
Countries
Bulgaria, Croatia, Poland
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.